Vermilion Life Sciences Ltd
Stuart is Chair of the Advisory Committee on Clinical Excellence Awards (ACCEA). He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years’ experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine, Takeda and UCB. He is the Founder of Vermilion Life Sciences, which provides consultancy services to reduce the time and cost of medicines development to improve patient access.
Stuart is also an Authority Member of the Human Tissue Authority, a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion'' for the UK Government''s Office for Life Sciences, Accelerated Access Review.
Reengineering Medicines Development
Exploring opportunities to reduce the cost and time of medicines development. How patient input, digital tools and real world data in real time can facilitate adaptive licensing and early regulator and payer discussions to generate early access.
EVEN MORE SEMINARS
Dr Bernadette A Lavery GenesisCare
Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment
Arie Parnham The Christie NHS Foundation Trust
Penile sparing and minimally invasive techniques for penile cancer
Dr. Matthew Prime Roche Diagnostics Information Solutions
Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology
Dr. Gerald Batist Segal Cancer Centre of Jewish General Hospital
Systemic Cancer Therapy: Achievements and Challenges that Lie Ahead
Dr Richter-Heine Praxisgemeinschaft im Camparihaus
Benefits of supporting medical garments in breast surgery